Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Ibrutinib plus venetoclax for previously treated CLL: CLARITY trial

Prof Peter Hillmen - University of Leeds, Leeds, UK
Ibrutinib plus venetoclax for previously treated CLL: CLARITY trial ( Prof Peter Hillmen - University of Leeds, Leeds, UK )
10 Dec 2017

Data from the JULIET trial of CTL019 for relapsed or refractory diffuse large B-cell lymphoma

Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA
Data from the JULIET trial of CTL019 for relapsed or refractory diffuse large B-cell lymphoma ( Dr Stephen Schuster - University of Pennsylvania, Philadelphia, USA )
10 Dec 2017

ECHELON-1 study of brentuximab vedotin as frontline therapy for Hodgkin's lymphoma

Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada
ECHELON-1 study of brentuximab vedotin as frontline therapy for Hodgkin's lymphoma ( Dr Joseph Connors - British Columbia Cancer Agency, Vancouver, Canada )
10 Dec 2017

Long term follow up on the ZUMA-1 trial for nHL

Dr Sattva Neelapu - MD Anderson Center, Houston, USA
Long term follow up on the ZUMA-1 trial for nHL ( Dr Sattva Neelapu - MD Anderson Center, Houston, USA )
10 Dec 2017

BLU-285 for advanced systemic mastocytosis

Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA
BLU-285 for advanced systemic mastocytosis ( Prof Daniel DeAngelo - Dana-Farber Cancer Institute, Boston, USA )
10 Dec 2017

SABCS 2017: The latest in CDK inhibition in breast cancer

Prof Nadia Harbeck, Dr Mark Beresford, Dr Shom Goel and Dr Sara Hurvitz
SABCS 2017: The latest in CDK inhibition in breast cancer ( Prof Nadia Harbeck, Dr Mark Beresford, Dr Shom Goel and Dr Sara Hurvitz )
10 Dec 2017

Autologous haematopoietic cell transplant for mantle cell lymphoma

Dr Stefan Barta - Fox Chase Cancer Center, Philadelphia, USA
Autologous haematopoietic cell transplant for mantle cell lymphoma ( Dr Stefan Barta - Fox Chase Cancer Center, Philadelphia, USA )
9 Dec 2017

Dexamethasone and the UKALL 2011 trial

Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Dexamethasone and the UKALL 2011 trial ( Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK )
9 Dec 2017

Circulating tumour cells may predict late recurrence in HR-positive breast cancer patients

Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
Circulating tumour cells may predict late recurrence in HR-positive breast cancer patients ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
9 Dec 2017

Postmenopausal women who lose weight may have reduced breast cancer risk

Prof Rowan Chlebowski - City of Hope, Duarte, USA
Postmenopausal women who lose weight may have reduced breast cancer risk ( Prof Rowan Chlebowski  - City of Hope, Duarte, USA )
9 Dec 2017

Talazoparib vs physicians choice for patients with mBRCA1 breast cancer

Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA
Talazoparib vs physicians choice for patients with mBRCA1 breast cancer ( Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA )
9 Dec 2017

CDK 4/6 inhibitors for older women with HR-positive breast cancer

Harpreet Singh - FDA, USA
CDK 4/6 inhibitors for older women with HR-positive breast cancer ( Harpreet Singh - FDA, USA )
9 Dec 2017